ASCO/ESMO 2020 - The Future of Head and Neck Cancer Treatment

The future role of immunotherapy in head and neck cancersПодробнее

ASCO/ESMO 2020 - KEYNOTE 048 Study Update, What Have We Learned?Подробнее

ASCO 2024 Top 3 Practice Changing Head & Neck Cancer StudiesПодробнее

ASCO 2020: head and neck cancer highlightsПодробнее

ESMO 2022 highlights in head and neck cancerПодробнее

Dr. Saba on the Future of Head and Neck Cancer TreatmentПодробнее

ASCO/ESMO 2020 - Head and Neck Cancer Updates - JAVELIN100 Trial UpdateПодробнее

ASCO/ESMO 2020 Debio 1143/ Xevinapant Study UpdateПодробнее

ASCO/ESMO 2020 PembroRAD Trial UpdateПодробнее

#ESMO21 Expert Video Report on head and neck cancerПодробнее

Head and neck cancer highlights at ASCO 2021Подробнее

LBA8_PR - KEYNOTE-048: Phase 3 study of first-line pembrolizumab in R/M HNSCCПодробнее

Head and neck cancer at ASCO 2022Подробнее

ASCO Town Hall on Head & Neck Cancers 06-25-2020Подробнее

Recent Data, Developments in Palliative Cancer Treatments - 2021 ASCO ESMO Head & Neck RecapПодробнее

Palliative Care and Studies for Incurable Head and Neck Cancers - 2021 ASCO ESMO Head & Neck RecapПодробнее

HPV and Head and Neck Cancers - 2021 ASCO ESMO Head & Neck RecapПодробнее

Update on Head and Neck Cancer from ASCO 2020Подробнее

Future directions for head and neck cancerПодробнее